Skip to main content

STONERIDGE INVESTMENT PARTNERS LLC

Position in PGEN — Precigen, Inc.

CIK 1108831 RADNOR, PA

Position in PGEN

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$62,407
-$4,999 QoQ
Shares Held
16,126
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 84% Shared 16% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STONERIDGE INVESTMENT PARTNERS LLC holds $1,324,200 across 8 Biotechnology names. PGEN ranks #7 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 PGEN
Precigen, Inc.
This page
16,126 $62,407

All Filings in PGEN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $62,407 16,126
2025-12-31 $67,406 16,126
2025-09-30 $45,464 13,819
2025-06-30 $97,527 68,681
2025-03-31 $102,334 68,681
2024-12-31 $76,922 68,681
2024-09-30 $53,787 56,618
2024-06-30 $89,456 56,618
2024-03-31 $82,096 56,618
2023-12-31 $23,279 17,373
2023-09-30 $24,669 17,373
2023-06-30 $19,978 17,373
2023-03-31 $18,415 17,373